571 related articles for article (PubMed ID: 16828124)
21. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
22. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
23. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
[TBL] [Abstract][Full Text] [Related]
24. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
[TBL] [Abstract][Full Text] [Related]
25. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Ramamoorthy R; Radhakrishnan M; Borah M
Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
[TBL] [Abstract][Full Text] [Related]
27. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng.
Park JH; Cha HY; Seo JJ; Hong JT; Han K; Oh KW
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):895-900. PubMed ID: 16002200
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test.
Raupp IM; Sereniki A; Virtuoso S; Ghislandi C; Cavalcanti E Silva EL; Trebien HA; Miguel OG; Andreatini R
J Ethnopharmacol; 2008 Jul; 118(2):295-9. PubMed ID: 18550307
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
[TBL] [Abstract][Full Text] [Related]
30. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
31. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
32. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Zaniewska M; McCreary AC; Wydra K; Filip M
Neuropharmacology; 2010 Jun; 58(7):1140-6. PubMed ID: 20153341
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
34. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
Kassai F; Schlumberger C; Kedves R; Pietraszek M; Jatzke C; Lendvai B; Gyertyán I; Danysz W
Behav Pharmacol; 2012 Aug; 23(4):397-406. PubMed ID: 22785385
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of two genetic animal models in behavioral tests of anxiety and depression.
Hinojosa FR; Spricigo L; Izídio GS; Brüske GR; Lopes DM; Ramos A
Behav Brain Res; 2006 Mar; 168(1):127-36. PubMed ID: 16324754
[TBL] [Abstract][Full Text] [Related]
36. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
[TBL] [Abstract][Full Text] [Related]
37. Antidepressant-like effect of agmatine is not mediated by serotonin.
Krass M; Wegener G; Vasar E; Volke V
Behav Brain Res; 2008 Apr; 188(2):324-8. PubMed ID: 18177953
[TBL] [Abstract][Full Text] [Related]
38. Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.
Pandey DK; Rajkumar R; Mahesh R; Radha R
J Pharm Pharmacol; 2008 Dec; 60(12):1643-50. PubMed ID: 19000369
[TBL] [Abstract][Full Text] [Related]
39. Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test.
Rocha-González HI; Meneses A; Carlton SM; Granados-Soto V
Pain; 2005 Sep; 117(1-2):182-92. PubMed ID: 16098671
[TBL] [Abstract][Full Text] [Related]
40. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze.
Violle N; Balandras F; Le Roux Y; Desor D; Schroeder H
Behav Brain Res; 2009 Oct; 203(1):35-42. PubMed ID: 19389429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
